Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRAX
PRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRAX News
RBC Capital Markets Initiates Praxis Precision with Outperform Rating
2d ago
seekingalpha
Latest Wall Street Rating Updates
2d ago
CNBC
Wedbush Lowers Praxis Price Target to $162 After POWER1 Miss
Jun 04 2026
NASDAQ.COM
US Stocks Close at All-Time Highs as AI Investments Surge
Jun 02 2026
NASDAQ.COM
US Stocks Rise Slightly, Tech Stocks Show Strong Rebound
Jun 02 2026
NASDAQ.COM
US Stocks Dip Slightly Amid Tech Sector Pressure
Jun 02 2026
NASDAQ.COM
Praxis Precision Medicines Reports POWER1 Study Failure
Jun 02 2026
seekingalpha
Praxis Precision Medicines Reports POWER1 Study Results for Vormatrigine
Jun 02 2026
NASDAQ.COM
Praxis Pauses Vormatrigine Study Amid Trial Setbacks
Jun 02 2026
stocktwits
POWER1 Study Results Fail to Meet Primary Success Measure
Jun 01 2026
Newsfilter
B Group Acquires Stake in Bright Minds Biosciences
May 21 2026
Yahoo Finance
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Praxis Precision Medicines FDA Accepts New Drug Application for Ulixacaltamide
Apr 14 2026
seekingalpha
Praxis Precision Medicines' NDA for Ulixacaltamide Accepted by FDA
Apr 14 2026
NASDAQ.COM
Praxis Receives FDA Review Acceptance for Ulixacaltamide NDA
Apr 14 2026
Newsfilter
PRAXIS PRECISION MEDICINES INC: RAYMOND JAMES BEGINS COVERAGE WITH A STRONG BUY RATING AND A TARGET PRICE OF $815
Apr 10 2026
moomoo
Show More News
